Insulin aspart, recombinant Subcutaneous and Talazoparib Tosylate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Talazoparib Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: talazoparib
Brand name: Talzenna
Synonyms: Talazoparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Talimogene laherparepvec
- Insulin aspart, recombinant Subcutaneous-Talimogene laherparepvec Injection
- Insulin aspart, recombinant Subcutaneous-Taliva
- Insulin aspart, recombinant Subcutaneous-Taltz
- Insulin aspart, recombinant Subcutaneous-Taltz (Ixekizumab Auto-Injectors)
- Insulin aspart, recombinant Subcutaneous-Taltz (Ixekizumab Prefilled Syringes)
- Talazoparib Tosylate-Insulin degludec
- Talazoparib Tosylate-Insulin Degludec (U-100) Prefilled Pens
- Talazoparib Tosylate-Insulin Degludec (U-100) Vials
- Talazoparib Tosylate-Insulin Degludec (U-200) Prefilled Pens
- Talazoparib Tosylate-Insulin degludec and liraglutide
- Talazoparib Tosylate-Insulin degludec and liraglutide Subcutaneous